Clinical Trial Update: Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating triple blockade of the renin-angiotensin-aldosterone system in proteinuric diabetic patients (Type 1 and Type 2) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Cook County Health | Conditions: Microalbuminuria, Macroalbuminuric Diabetic Nephropathy | Phase 4 | Status: TERMINATED